Lantheus. has been granted a patent for a method that enables secure uploading and review of medical images and metadata to a network-based analysis platform. The system features a user-friendly interface that allows medical practitioners to manage sensitive data effectively before upload. GlobalData’s report on Lantheus gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Lantheus, was a key innovation area identified from patents. Lantheus's grant share as of July 2024 was 50%. Grant share is based on the ratio of number of grants to total number of patents.
Secure medical image upload and analysis system
The patent US12032722B2 outlines a method and system for the interactive display of data from multiple medical imaging studies through a network-based analysis or decision support platform. The method involves accessing a data table that contains various study summary variables, including a prostate cancer indication. A graphical user interface (GUI) is utilized to present graphical filter control elements, allowing users to select specific sub-ranges of values for these variables. The system then filters the data based on user selections and updates the graphical representations, which visually depict the distribution of values associated with the selected medical imaging studies. This process can be repeated for multiple variables, enhancing the user's ability to analyze and interpret the data effectively.
Additionally, the claims specify that the study summary variables may include prior therapy values and prostate-specific antigen (PSA) test levels, as well as imaging modality variables such as Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), x-ray Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and bone-scan imaging. The graphical data representations can take various forms, including bar graphs, pie charts, and histograms. The system is designed to facilitate the categorization of patients based on their cancer status, which may include indications such as screening, recurrent, suspected recurrence, newly diagnosed, and metastatic. Overall, this patent presents a comprehensive approach to enhancing the visualization and analysis of medical imaging data, thereby supporting clinical decision-making.
To know more about GlobalData’s detailed insights on Lantheus, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
